These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1707218)

  • 1. [Study of the long-term administration of ofloxacin to the patients following transurethral resection of the prostate].
    Morita M; Hasuda A; Suzuki K
    Hinyokika Kiyo; 1991 Jan; 37(1):99-103. PubMed ID: 1707218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of oral ofloxacin in 3-day therapy for transurethral resection of the prostate].
    Morita M; Ito S; Suzuki K
    Hinyokika Kiyo; 1992 Jul; 38(7):869-74. PubMed ID: 1381870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
    Tsuji Y; Okamura K; Miyake K; Ito H; Kinukawa T; Otani T; Narushima M; Kanai S; Takagi Y; Murase T
    Hinyokika Kiyo; 1993 Dec; 39(12):1145-52. PubMed ID: 7506866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of ciprofloxacine antibiotic prophylaxis of infectious complications after TUR of the prostate].
    Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Veliev EI; Kopylov VV; Iskorostinskiĭ EV; Kirekhin IV
    Urologiia; 2005; (5):21-5. PubMed ID: 16281834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic and chemotherapeutic efficacy of pivmecillinam (PMPC) against infections after TUR-P and prostatectomy].
    Maru A; Mitsuhashi K; Shiba T; Ohashi N; Fujieda J; Nishida T; Okoshi R; Kusakai Y; Amino I; Kaneda T
    Hinyokika Kiyo; 1983 Feb; 29(2):245-53. PubMed ID: 6203380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
    Valdevenito Sepúlveda JP
    Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transurethral electrovaporization of the prostate (TUV-P): comparative study with transurethral resection (TUR-P)].
    Miyata Y; Furukawa M
    Hinyokika Kiyo; 1997 Jul; 43(7):477-82. PubMed ID: 9282292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Using setegis (terasosine) in early postoperative period after transurethral prostate resection].
    Teodorovich OV; Zabrodina NB; Bochkarev AB
    Urologiia; 2009; (3):62-4. PubMed ID: 19673124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy after prostatectomy--effects of long term administration of Pivmecillinam (PMPC)].
    Sagawa S; Takaha M; Sonoda T; Shin T; Yano H; Mizutani S; Sakurai T; Kotake T; Nakamura T; Nagano S
    Hinyokika Kiyo; 1984 Mar; 30(3):423-30. PubMed ID: 6205570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of transurethral resection of prostate plus incision (TUR-P+I) for benign prostatic hypertrophy].
    Ishizaka K; Ohtsuka Y; Nagamatsu H; Fukui I; Oshima H
    Hinyokika Kiyo; 1996 Mar; 42(3):207-11. PubMed ID: 8619390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The course of pyuria after transurethral resection of the prostate and factor analysis of its duration].
    Okamura K; Takaba H; Ito K; Shimoji T
    Hinyokika Kiyo; 1987 Jun; 33(6):889-93. PubMed ID: 2445189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.
    Nørby B; Nielsen HV; Frimodt-Møller PC
    Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Semi-radical transurethral resection of the prostate for small benign prostatic hyperplasia].
    Watanabe J; Hiraoka Y; Akimoto M
    Hinyokika Kiyo; 1994 Sep; 40(9):789-94. PubMed ID: 7528463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index.
    Han DH; Jeong YS; Choo MS; Lee KS
    Urology; 2008 Apr; 71(4):657-61. PubMed ID: 18313105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of lower urinary tract symptoms and urinary flow rate after transurethral resection of the prostate].
    Tanaka Y; Masumori N; Tsukamoto T; Furuya S; Furuya R; Ogura H
    Hinyokika Kiyo; 2007 Jun; 53(6):369-73. PubMed ID: 17628933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.